A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as ...

Is the Galleri multi-cancer blood test worth it? A doctor's analyses of real-world performance data. Learn why no major ...

In a significant move towards enhancing cancer detection and treatment, telehealth company Hims & Hers has announced the addition of Grail's Galleri multi-cancer blood test to its extensive digital ...

Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech has now sent off ...

Comprehensive biomarker testing is crucial for NSCLC treatment, yet disparities exist between academic and community settings ...

Cellares will establish a standardized platform manufacturing process on the Cell Shuttle and platform release assays on the Cell Q.

The key alterations sought are FGFR3 activating mutations or fusions/rearrangements (“susceptible” alterations), for potential use of the FGFR inhibitor erdafitinib (Balversa), and HER2 IHC expression ...

Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the ...

Are you looking for migraine relief or a fast treatment to stop your headache, ease your mind and release all your stress? Try this compilation of one hour of soothing and curative music! With gentle ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Curative's focus has shifted ...

A/B testing is the gold standard of experimentation. It is meant to help companies make faster, better, data-driven decisions. But too often, it does the opposite. The meeting starts with optimism: a ...